iRhythm Cash Flow Statement
NASDAQ: IRTCHealth CareMedical/Dental InstrumentsUSD
106.70+4.10 (+4.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
iRhythm free cash flow
In fiscal 2025, iRhythm generated $80.9 million of operating cash flow and spent $46.3 million on capital expenditures. That left free cash flow of $34.5 million, a free-cash-flow margin of 4.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
iRhythm cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -44.55M | -113.29M | -123.41M | -116.16M | -101.36M | -43.83M | -54.57M | -50.38M | -29.74M | -20.90M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 20.70M | 20.70M | 16.30M | 13.40M | 9.80M | 6.90M | 3.44M | 2.27M | 1.60M | 568.00K |
| Stock-Based Compensation | 88.28M | 75.98M | 77.20M | 57.74M | 54.53M | 41.52M | 26.24M | 16.33M | 9.75M | 1.87M |
| Change in Working Capital | -80.01M | -94.62M | -54.37M | -41.85M | -44.66M | -45.27M | -19.76M | -13.40M | -6.88M | -5.50M |
| Operating Cash Flow | 80.86M | 3.39M | -50.10M | -23.01M | -37.75M | -13.76M | -21.86M | -29.09M | -14.91M | -16.65M |
| Capital Expenditures | -46.34M | -33.94M | -40.42M | -29.83M | -28.07M | -13.55M | -20.46M | -5.18M | -3.56M | -2.76M |
| Investing Cash Flow | -277.06M | -122.98M | -1.21M | -52.43M | 105.26M | -132.39M | -89.27M | 34.14M | -34.68M | -68.17M |
| Share Repurchases | 0 | -25.00M | 0 | 0 | — | — | — | — | — | — |
| Debt Issued | — | — | 0 | 35.00M | 0 | 0 | 0 | 35.00M | 0 | — |
| Debt Repaid | — | — | 0 | -21.39M | -11.67M | -1.94M | 0 | -31.50M | 0 | — |
| Financing Cash Flow | 12.61M | 511.38M | 8.82M | 26.72M | -28.58M | 214.32M | 111.58M | 6.30M | 6.53M | 111.25M |
| Net Change in Cash | -183.59M | 391.78M | -42.66M | -48.73M | 38.93M | 68.17M | 439.00K | 11.35M | -43.06M | 26.43M |
| Free Cash Flow | 34.52M | -30.55M | -90.53M | -52.84M | -65.82M | -27.31M | -42.32M | -34.27M | -18.47M | -19.41M |
This table shows 10 annual periods of iRhythm's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRTC's reporting calendar. What is a cash flow statement?